semaglutide fda shortage status january 2025 Novo's Wegovy and Ozempic removed from US list, compounders on notice End of Semaglutide Shortage Means
Description
As featured in a recent GQ article on the peptide recategorization, Beverly Hills Rejuvenation Centers own Chief Innovation Officer Sanjiv Lal weighed in on what this means for patients and the future of peptide medicine

The American Society of Anesthesiologists (ASA) first warned about the surgical risk of pulmonary aspiration from Ozempic in July 2023, when it issued guidance for the medical community about the importance of patients stopping use of GLP-1 medications before elective surgery

PCPs estimated that nearly 30% of their patients have requested GLP-1 prescriptions for weight loss
Funding The PIONEER REAL studies and this pooled anaysis are sponsored by Novo Nordisk A/S

You can withdraw from the program, but WeightWatchers will not cancel the payments until the term you chose is up
